Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,266,096
-$1,409,997 QoQ
Shares Held
94,107
-28.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#899
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2022CallValue
$31
CallShares
10
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $33,612,604 across 12 Drug Manufacturers - General names. PFE ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,377 | $11,247,056 | |
| 2 | ABBV |
AbbVie Inc.
|
22,380 | $5,631,703 | |
| 3 | JNJ |
Johnson & Johnson
|
20,128 | $5,111,908 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,013 | $3,728,170 | |
| 5 | PFE |
Pfizer Inc
This page
|
94,107 | $2,266,096 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
34,471 | $1,986,219 | |
| 7 | AMGN |
Amgen Inc
|
4,406 | $1,595,500 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,409 | $809,713 |
All Filings in PFE
Export CSV
37 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,266,096 | 94,107 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,676,093 | 130,915 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,584,379 | 143,951 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,036,030 | 79,907 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,029,081 | 83,708 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,178,251 | 85,961 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,836,667 | 106,923 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,273,403 | 113,110 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,369,659 | 120,431 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,669,632 | 132,239 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,774,924 | 96,385 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,493,796 | 105,330 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $3,681,461 | 100,367 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,828,835 | 93,844 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $31 | 10 | Call | Sole | 2023-02-22 | |
| 2022-12-31 | $4,957,162 | 96,744 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $4,257,104 | 97,283 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $437 | 10 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $681 | 13 | Call | Sole | 2022-08-10 | |
| 2022-06-30 | $5,171,066 | 98,628 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $5,729,385 | 110,670 | Shares | Sole | 2022-05-16 | |
| 2022-03-31 | $673 | 13 | Call | Sole | 2022-05-16 | |
| 2021-12-31 | $6,808,760 | 115,305 | Shares | Sole | 2022-01-18 | |
| 2021-12-31 | $2,775 | 47 | Call | Sole | 2022-01-18 | |
| 2021-09-30 | $5,518,828 | 128,315 | Shares | Sole | 2021-11-03 | |
| 2021-09-30 | $1,677 | 39 | Call | Sole | 2021-11-03 | |
| 2021-06-30 | $391 | 10 | Call | Sole | 2021-07-29 | |
| 2021-06-30 | $4,508,608 | 115,133 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $4,252,858 | 117,385 | Shares | Sole | 2021-05-04 | |
| 2021-03-31 | $326 | 9 | Call | Sole | 2021-05-04 | |
| 2020-12-31 | $331 | 9 | Put | Sole | 2021-01-14 | |
| 2020-12-31 | $3,757,638 | 102,082 | Shares | Sole | 2021-01-14 | |
| 2020-12-31 | $515 | 14 | Call | Sole | 2021-01-14 | |
| 2020-09-30 | $330 | 9 | Call | Sole | 2020-11-02 | |
| 2020-09-30 | $3,409,426 | 92,900 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,112,487 | 64,602 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,076,227 | 63,610 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||